1例重症脑脊液分流器感染患者的药学监护
摘要
目的:探讨对特殊患者实施药学监护的方法和意义。方法:为1例重症脑脊液分流器感染患者提供药学监护,并对患者进行用药分析。结果:临床药师可以从药物不良反应,治疗药物监测,药动学/药效学和药物稳定性等方面作为切入点,为重症患者提供药学监护。结论:临床药师是治疗团队中的重要组成部分,通过对特殊患者提供药学服务,既提高了自身临床知识,又可发挥药学优势,为医生合理用药提供建议。
出处
《中国医院药学杂志》
CAS
CSCD
北大核心
2010年第18期1597-1599,共3页
Chinese Journal of Hospital Pharmacy
参考文献17
-
1Ragel BT, Browd SR, Schmidt RH. Surgical shunt infection: significant reduction when using intraventricular and systemic antibiotic agents[J]. J Neurosurg, 2006,105 (2) : 242-247.
-
2Wang KW,Chang WN, Shin TY, et al. Infection of cerebrospinal fluid shunts: causative pathogens,clinical features and outcomes [J]. Jpn J Infect Dis. 2004,57:44-48.
-
3Schoenbaum SIC,Gardner P,Shillito J. Infections of cerebrospinal fluid shunts: epidemiology,clinical manifestions,and therapy[J]. J Infect Dis. 1975,131 : 543-552.
-
4Govender ST, Nathoo N, Van Dellen JR. Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus [J]. J Neurosurg. 2003,99(5):831-839.
-
5Micromedex healthcare serie [DB/CD]. Thomson Heahhcare, 2009,141 [2009-10-20].
-
6Mattoes HM, Kuti JL, Drusano GL, et al. Optimizing antimicrobial pharmacodynamics: dosage strategies for meropenem [J]. Clin Ther,2004,26(8) : 1187-1198.
-
7Rodriguez-Cerrato V, McCoig CC, Michelow IC. Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coil meningitis [J]. Antimicrob Agents Chemother, 2001 ,45(11) :3092-3097.
-
8Kanellakopoulou KK, Pagoulayou A, Stroumpoulis K, et al. Pharmacokinetics of moxifloxacin in non-inflamed cerebrospinal fluid of human: implication for a bactericidal effect [J]. J Antimicrob Chemother, 2008,61, 1328-1331.
-
9Barth J, Jager D, Mundkowski R, et al. Single- and multipledose pharmacokinetics of intravenous moxifloxacin in patients with severe hepatic impairment [J]. J Antimicrob Chemother, 2008,62 (3) : 575-578.
-
10Ambrose PG, Grasela DM,Grasela TH,et al. Pharmacodynamics of fluoroquinolones against streptococcus pneumoniae in pa tients with community-acquired respiratory tract infections [J]. Antimicrob Agents Chemother, 2001,45 : 2793-2797.
二级参考文献38
-
1李家泰,齐慧敏,李耘,代表中国细菌耐药监测研究组.2002—2003年中国医院和社区获得性感染革兰阳性细菌耐药监测研究[J].中华检验医学杂志,2005,28(3):254-265. 被引量:225
-
2George R,Leibrock L,Ebstein M.Long term analysis of cerebrospinal fluid shunt infections.A 25 years experience [J].J Neurosurg,1997,51(6):804 -811.
-
3Renier D,Lacombe J,Pierre-Kahn A,et al.Factors causing acute shunt infection.Computer analysis of 1174 operations [J].J Neurosurg,1984,61(6):1072-1078.
-
4Choksey MS,Malik lA.Zero tolerance to shunt infections:can it be achieved? [J].J Neurol Neurosurg Psychiatry,2004,75 (1):87 -91.
-
5Livni G,Yuhas Y,Ashkenazi S,et al.In vitro bacterial adherence to ventriculoperitoneal shunts [J].Pediatr Neurosurg,2004,40(2):64- 69.
-
6Wang KW,Chang WN,Shih TY,et al.Infection of cerebrospinal fluid shunts:causative pathogens,clinical features,and outcomes [J].Jpn J Infect Dis,2004,57 (2):44 -48.
-
7Schreffler RT,Schreffler AJ,Wittler RR.Treatment of cerebrospinal fluid shunt infections:a decision analysis [J].Pediatr Infect Dis J,2002,21(7):632 -636.
-
8De Bels D,Korinek AM,Bismuth R,et al.Empirical treatment of adult postsurgical nosocomial meningitis[J].Acta Neurochir (Wien),2002,144(10):989 -995.
-
9Owen R,Pittman T.Delayed external ventriculoperitoneal shunt infection [J].J Ky Med Assoc,2004,102(8):349 -352.
-
10KUTI J J,NICOLAU D P. Making the most of surveillance studies summary of the OPTAMA program [ J ] . Diagn Microbiol Infect Dis,2005,53(4) :281- 287.
共引文献50
-
1申青仙.脑室-腹腔分流加颅骨修补术后并发症的观察与护理[J].医学信息(医学与计算机应用),2014,0(26):256-256. 被引量:1
-
2陈富涛,李其林,王凡,侯敏,贾映海,张洪良.脑室-腹腔分流术后感染的防治[J].四川医学,2007,28(7):758-759. 被引量:1
-
3李其林,王凡,侯敏,贾映海.脑室-腹腔分流术后感染原因分析及治疗[J].中华神经外科杂志,2007,23(8):615-616. 被引量:11
-
4杨利孙,陈飞,王奕鹏,邵征宇,姜源,沈敬敬.不同手术路径对脑室-腹腔分流手术效果的影响[J].中华神经外科疾病研究杂志,2008,7(1):60-63. 被引量:9
-
5王少明,吕连杰,邓磊,徐立靖,刘艳艳.脑室-腹腔分流术后感染原因分析及治疗[J].中国城乡企业卫生,2008,23(1):25-26.
-
6王兆岭,陈加焱.颅骨修补及脑室-腹腔分流治疗脑外伤的临床效果分析[J].中国临床神经科学,2008,16(5):536-538. 被引量:26
-
7王光明,陈儇,王海峰,付双林.自制腹腔穿刺针辅助脑室腹腔分流术在老年脑积水治疗中的应用[J].中国老年学杂志,2008,28(23):2375-2376. 被引量:5
-
8王兆岭.脑外伤后颅骨缺损伴脑积水的临床疗效分析[J].中华全科医学,2009,7(4):351-353. 被引量:8
-
9于广华,裔照国,高璀乡,张国培,李芳.亚胺培南/西司他丁给药方案基于PK/PD的蒙特卡洛模拟[J].中国医院药学杂志,2009,29(17):1495-1497. 被引量:5
-
10王丽,汤子孝,白希林,杨慧,周媛,张松,普长兴,孙建明,马燕琳,李特.常用抗菌药物配液的放置环境对药效的影响[J].医药导报,2010,29(1):114-116. 被引量:3
-
1梁宇,韩吉.脑室-腹腔分流手术后感染腹膜炎患者的药学监护[J].医药导报,2013,32(6):810-812. 被引量:1
-
2向前.粘质沙雷菌的耐药机制[J].国外医学(流行病学.传染病学分册),1999,26(3):128-131. 被引量:6
-
3刘东华,鲁艳,王少敏.神经外科粘质沙雷菌所致下呼吸道感染分析[J].医药论坛杂志,2009,30(9):47-48. 被引量:1
-
4高羽.1例儿童急性淋巴细胞白血病患儿药学监护实践[J].中国药业,2014,23(16):94-96. 被引量:1
-
5王嵩,李牧,肖福顺,赵林珊.应用可调压式分流管治疗脑积水[J].当代医学,2008,14(7):68-69. 被引量:2
-
6路娟,陈淑兰,董娟,宋熙瑶,刘文博,赵金英.1909株革兰氏阴性杆菌中产ESBLs细菌分离率及耐药性[J].哈尔滨医科大学学报,2002,36(1):78-79. 被引量:1
-
7陈同绘,李珍大.72株质沙雷菌对15种抗菌药物的耐药性分析[J].医学检验进修杂志,2000,7(2):21-22. 被引量:4
-
8胡云建,陈东科,陶凤容,许宏涛,艾效曼,厉保秋.替比培南匹伏脂的体外抗菌作用研究[J].中国临床药理学杂志,2012,28(12):950-954. 被引量:8
-
9李家斌,李旭,马亦林,俞云松.TEM-104编码基因的克隆与原核表达[J].中华传染病杂志,2004,22(6):403-405. 被引量:2
-
10黄毅岚,江启蓉,杨虹,叶云.肾脏疾病患者的药学监护[J].中国药房,2009,20(23):1832-1834. 被引量:4